Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

Rockrat,

I have no facts regarding Mylan's position regarding generic copaxone. I have own them for a few years and think very highly of their management.

To start off, whatever income Mylan would garner from a copaxone equivalent would be nothing more than a rounding error at this point so I don't think their management is losing any sleep over this.

I'm sure they'll get approved along with other companies at some point and then no one will make any money. We have to remember that when these companies first looked at Copaxone it was a whole different story.

You say that Natco's drug doesn't look like it cuts the mustard, well yesterday morning you could have said the same thing about Momenta.

Mylan has gained about 50% a year for the last five years and I can live with that pain.......